302 related articles for article (PubMed ID: 11268446)
1. Randomized controlled trial of 5-fluorouracil (5-FU) infusion combined with 1-hexylcarbamoyl-5-fluorouracil (HCFU) oral administration and HCFU alone as postoperative adjuvant chemotherapy for colorectal cancer.
Iwagaki H; Tanaka N; Esato K; Kaibara N; Sano K; Dohi K; Nakamura T; Nakasato H; Orita K
Anticancer Res; 2000; 20(5C):3727-34. PubMed ID: 11268446
[TBL] [Abstract][Full Text] [Related]
2. Post-operative adjuvant chemotherapy for colorectal cancer with 5-fluorouracil (5-FU) infusion combined with 1-hexylcarbamoyl-5-fluorouracil (HCFU) oral administration after curative resection.
Iwagaki H; Tanaka N; Esato K; Kaibara N; Sano K; Dohi K; Toge T; Nakamura T; Nakasato H; Orita K
Anticancer Res; 2001; 21(6A):4163-8. PubMed ID: 11911312
[TBL] [Abstract][Full Text] [Related]
3. Postoperative adjuvant chemotherapy with 1-hexylcarbamoyl-5-fluorouracil in patients with colorectal cancer and at a high risk for recurrence.
Maehara Y; Sugimachi K; Ogawa M; Kakegawa T; Tomita M; Akiyoshi T
Anticancer Res; 1998; 18(6B):4629-34. PubMed ID: 9891531
[TBL] [Abstract][Full Text] [Related]
4. Postoperative chemotherapy for colorectal cancer by combining 5-fluorouracil infusion and 1-hexylcarbamoyl-5-fluorouracil administration after curative resection.
Sugimachi K; Maehara Y; Ogawa M; Kakegawa T; Tomita M; Akiyoshi T
Cancer; 1996 Jan; 77(1):36-43. PubMed ID: 8630937
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled trial of the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexylcarbamoyl-5-fluorouracil and uracil/tegafur.
Watanabe M; Nishida O; Kunii Y; Kodaira S; Takahashi T; Tominaga T; Hojyo K; Kato T; Niimoto M; Kunitomo K; Isomoto H; Ohashi Y; Yasutomi M
Int J Clin Oncol; 2004 Apr; 9(2):98-106. PubMed ID: 15108041
[TBL] [Abstract][Full Text] [Related]
6. [Multicenter comparative study of the recurrence-inhibitory effect of oral fluoropyrimidine drugs in patients with colorectal cancer following curative resection].
Sadahiro S; Mitomi T; Noto T; Kumada K; Hiki Y; Yamakawa T; Amano T; Oki S; Otani Y; Oka H; Takahashi T; Takemiya S; Nishiyama K; Yamamura T; Tsuchiya S; Ogawa N;
Gan To Kagaku Ryoho; 2005 Jul; 32(7):997-1005. PubMed ID: 16044962
[TBL] [Abstract][Full Text] [Related]
7. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan.
Jpn J Clin Oncol; 1995 Jun; 25(3):91-103. PubMed ID: 7596054
[TBL] [Abstract][Full Text] [Related]
8. [Appropriate duration of postoperative oral adjuvant chemotherapy with HCFU for colorectal cancer].
Ito K; Okushiba S; Morikawa T; Kondo S; Katoh H
Gan To Kagaku Ryoho; 2004 Jan; 31(1):55-9. PubMed ID: 14750322
[TBL] [Abstract][Full Text] [Related]
9. [Prospective controlled study on the usefulness of Carmofur as a postoperative adjuvant chemotherapy for colorectal cancer].
Yasutomi M; Takahashi T; Kodaira S; Hojo K; Kato T; Ogawa M; Ichihashi H; Tominaga T; Tamada R; Kunii Y; Kikuchi K
Gan To Kagaku Ryoho; 1997 Oct; 24(13):1953-60. PubMed ID: 9350242
[TBL] [Abstract][Full Text] [Related]
10. A multicenter randomized study comparing 5-fluorouracil continuous infusion (ci) plus 1-hexylcarbamoyl-5-fluorouracil and 5-FU ci alone in colorectal cancer.
Kotake K; Ohashi Y; Kodaira S; Koyama Y;
Oncol Rep; 2005 Jul; 14(1):129-34. PubMed ID: 15944779
[TBL] [Abstract][Full Text] [Related]
11. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of the efficacy of adjuvant chemotherapy for colon cancer with combination therapy incorporating the oral pyrimidine 1-hexylcarbamoyl-5-fluorouracil.
Watanabe M; Kodaira S; Takahashi T; Tominaga T; Hojo K; Kato T; Kunitomo K; Isomoto H; Ohashi Y; Yasutomi M
Langenbecks Arch Surg; 2006 Aug; 391(4):330-7. PubMed ID: 16823593
[TBL] [Abstract][Full Text] [Related]
13. Optimum duration of oral adjuvant chemotherapy of HCFU for colorectal cancer; review of 5-year follow-up.
Ito K; Kato T; Koike A; Miura K; Yamaguchi A; Sakou T; Takagi H
Anticancer Res; 2000; 20(6C):4681-6. PubMed ID: 11205200
[TBL] [Abstract][Full Text] [Related]
14. Optimal duration of oral adjuvant chemotherapy with Carmofur in the colorectal cancer patients: the Kansai Carmofur Study Group trial III.
Nakamura T; Ohno M; Tabuchi Y; Kamigaki T; Fujii H; Yamagishi H; Kuroda Y;
Int J Oncol; 2001 Aug; 19(2):291-8. PubMed ID: 11445841
[TBL] [Abstract][Full Text] [Related]
15. Results of a randomized trial with or without 5-FU-based preoperative chemotherapy followed by postoperative chemotherapy in resected colon and rectal carcinoma.
Colorectal Cancer Chemotherapy Study Group of Japan - The 2nd Trial
Jpn J Clin Oncol; 2003 Jun; 33(6):288-96. PubMed ID: 12913083
[TBL] [Abstract][Full Text] [Related]
16. [Prospective adjuvant chemotherapy of mitomycin C plus HCFU for colorectal cancer (2d report)--6-year survival after surgery: Tokai Cooperative Study Group of Surgical Adjuvant Chemotherapy].
Ichihashi H; Yamauchi M; Watanabe T; Takagi H; Kondo T
Gan No Rinsho; 1988 Apr; 34(4):451-6. PubMed ID: 3128670
[TBL] [Abstract][Full Text] [Related]
17. Oral adjuvant chemotherapy with carmofur (HCFU) for colorectal cancer: five-year follow-up. Tokai HCFU Study Group--third study on colorectal cancer.
Ito K; Yamaguchi A; Miura K; Kato T; Baba S; Matsumoto S; Ishii M; Takagi H
J Surg Oncol; 1996 Oct; 63(2):107-11. PubMed ID: 8888803
[TBL] [Abstract][Full Text] [Related]
18. Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy.
Hemminki A; Mecklin JP; Järvinen H; Aaltonen LA; Joensuu H
Gastroenterology; 2000 Oct; 119(4):921-8. PubMed ID: 11040179
[TBL] [Abstract][Full Text] [Related]
19. 1-hexylcarbamoyl-5-fluorouracil + cyclophosphamide + tamoxifen versus CMF + tamoxifen in women with lymph node-positive breast cancer after primary surgery: a randomized controlled trial.
Tominaga T; Kimura M; Asaga T; Yoshida M; Awane H; Koyama H; Takatsuka Y; Mitsuyama S; Ikeda T; Ogita M; Aoyama H; Sano M; Abe R; Nishi T; Wada T; Danno M; Toi M; Takashima S
Oncol Rep; 2004 Oct; 12(4):797-803. PubMed ID: 15375502
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of a continuous venous infusion of fluorouracil and daily divided dose cisplatin as adjuvant therapy in resectable colorectal cancer: a prospective randomized trial.
Hata F; Sasaki K; Hirata K; Yamamitsu S; Shirasaka T
Surg Today; 2008; 38(7):623-32. PubMed ID: 18612787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
